enGene Therapeutics Inc. – Filings and Transcripts

NASDAQ: ENGN
Share price (9/24/26): $1.92
Market cap (9/24/26): $129 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 07/31/26 Q3

ended 04/30/26 Q2

ended 01/31/26 Q1

ended 10/31/25 FY 2025 – amended

ended 10/31/25 FY 2025

Prospectuses and Registrations Filter

Registration of securities for employees

Prospectus supplement for primary offering

Shelf registration

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Ownership Filter

Grossman William

Venrock Healthcare Capital Partners III, L.P.

Perceptive Advisors LLC

Deep Track Capital, LP

Invus Global Management, LLC

News Filter

Reports Third Quarter 2026 Financial Results and Provides Business Update

Investor Presentation

Investor Presentation

Focuses Board to Support Planned Upcoming Regulatory and Commercial Milestones

Cost of Exit or Disposal Activities, Change in Directors, Officers or Compensation

Proxies Filter

Definitive proxy

Definitive proxy

Definitive proxy

Other Filter

Scanned paper annual report submission

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Scanned paper annual report submission